Prognosis of small hepatocellular carcinoma in relations to treatment. Study of 100 patients.:Study of 100 Patients

概要

論文の詳細を見る
Survivals for 100 patients with small hepatocellular carcinoma, less than 5cm in diameter, were analyzed based on different therapeutic modalities and Child's gradings.When analysis was made with respect to major therapeutic modalities wihtout considering stage, the median survival was 35.0 months for 34 patients treated by surgery, 28.8 months for 20 patients treated by transcatheter arterial embolization (TAE), 10.6 months for 25 patients treated by intraarterial chemotherapy (IAC), and 9.7 months for 17 patients who received no specific treatment.When patients were divided into 3 stages without considering treatment, the median survival was 37.1 months for 37 Child's A patients, 16.2 months for 37 Child's B patients and 1.6 months for 26 Child's C patients. When the effect of major therapeutic modalities on survival was analyzed with considering Child's grading, the survival rate for surgery was better than those for TAE and IAC in Child's A patients. Among Child's B patients, the survival rate for TAE was better than others. Among Child's C patients, there were no significant differences in the survival rate of each treatment or no treatment.These results suggest that the prognosis depends on treatment given and Child's gradings, and also suggest that surgery will be indicated as a first choice in Child's A, TAE will be preferred in Child's B and a new treatment should be developed for Child's C patients with small hepatocellular carcinoma.Regardless of treatment, the major cause of death was hepatic failure and cancer death was rare.
財団法人日本消化器病学会の論文

Prognosis of small hepatocellular carcinoma in relations to treatment. Study of 100 patients.:Study of 100 Patients

スポンサーリンク

概要

著者

関連論文

スポンサーリンク